elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36250418-521CFA18-65C7-412B-AE12-F8EC9357DBE2
Q36250418-521CFA18-65C7-412B-AE12-F8EC9357DBE2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36250418-521CFA18-65C7-412B-AE12-F8EC9357DBE2
A switch in therapy to a reverse transcriptase inhibitor sparing combination of lopinavir/ritonavir and raltegravir in virologically suppressed HIV-infected patients: a pilot randomized trial to assess efficacy and safety profile: the KITE study.
P304
Q36250418-521CFA18-65C7-412B-AE12-F8EC9357DBE2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36250418-521CFA18-65C7-412B-AE12-F8EC9357DBE2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6c22515faad5b9b2cc136a6836003fcaab4ceaca
P304
1196-1206
http://www.w3.org/2001/XMLSchema#string